Search

Belinda Tsao Nivaggioli

from Atherton, CA
Age ~57

Belinda Nivaggioli Phones & Addresses

  • 99 Lupin Ln, Atherton, CA 94027 (650) 325-7777
  • Lupin Ln, Atherton, CA 94027
  • South San Francisco, CA
  • Redwood City, CA
  • Tahoe Vista, CA
  • 12020 Greenhills Ct, Los Altos, CA 94022
  • Los Altos Hills, CA
  • Palo Alto, CA
  • Boston, MA
  • Newark, NJ
  • San Mateo, CA
  • San Francisco, CA
  • 99 Lupin Ln, Atherton, CA 94027

Work

Company: Avicena group, inc. Position: Ceo

Education

School / High School: University of Toronto 1988 to 1993

Industries

Biotechnology

Resumes

Resumes

Belinda Nivaggioli Photo 1

Ceo At Avicena Group, Inc.

View page
Position:
CEO at Avicena Group, Inc.
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Avicena Group, Inc.
CEO
Education:
University of Toronto 1988 - 1993

Business Records

Name / Title
Company / Classification
Phones & Addresses
Belinda Nivaggioli
Chairman
IT & Eglobal Inc
Custom Computer Programming Services · Research and Development in the Physical, Engineering, and L
228 Hamilton Ave, Palo Alto, CA 94301
(650) 798-5310
Belinda Nivaggioli
President
AVICENA GROUP, INC
Commercial Physical Research · Biotechnology Products & Servi
228 Hamilton Ave, Palo Alto, CA 94301
(415) 397-2880, (415) 397-2898
Belinda Nivaggioli
President
Peninsula Skincare Labs, Inc.
Pharmaceuticals · Mfg Toilet Preparations
601 Gtwy Blvd, South San Francisco, CA 94080
1180 Peachtree St NE, Atlanta, GA 30309
PO Box 7249, Redwood City, CA 94063

Publications

Us Patents

Creatine-Ligand Compounds And Methods Of Use Thereof

View page
US Patent:
20080003208, Jan 3, 2008
Filed:
May 11, 2007
Appl. No.:
11/803008
Inventors:
Belinda Nivaggioli - Atherton CA, US
Assignee:
AVICENA FROUP, INC. - Boston MA
International Classification:
A61K 31/195
A61K 31/34
A61K 31/557
A61K 31/65
A61P 17/00
A61P 25/00
A61P 25/16
C07C 279/10
C07C 57/42
C07C 59/11
C07D 307/33
C07F 9/08
US Classification:
424094100, 514152000, 514474000, 514560000, 514565000, 549315000, 558161000, 562470000, 562471000, 562495000, 562560000
Abstract:
The present invention provides methods of treating creatine responsive states, such as a neurological disorder (i.e., Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and creatine transporter defect) or a skin disorder, by administering a creatine-ligand compound, alone or in combination with an anti-inflammatory compound, to a subject.

Creatine Compositions For Skin Treatment

View page
US Patent:
20080206170, Aug 28, 2008
Filed:
Dec 7, 2007
Appl. No.:
11/999994
Inventors:
Belinda Tsao Nivaggioli - Atherton CA, US
Bolko Zu Stolberg - Palo Alto CA, US
Maisie Wong-Paredes - Redwood City CA, US
International Classification:
A61K 31/195
A61K 8/40
A61Q 19/00
A61Q 17/04
A61P 17/00
A61P 37/00
US Classification:
424 59, 514565
Abstract:
The present invention relates to the use of creatine compounds, such as, for example, creatine monohydrate, creatine pyruvate and creatine ascorbate, for the treatment of skin.

Use Of Creatine Compounds For The Treatment Of Eye Disorders

View page
US Patent:
20090005450, Jan 1, 2009
Filed:
Apr 9, 2008
Appl. No.:
12/082240
Inventors:
Belinda Tsao Nivaggioli - Atherton CA, US
International Classification:
A61K 31/195
A61P 27/02
US Classification:
514565
Abstract:
The present invention provides methods of treating an eye disorder (i.e., glaucoma, macular degeneration, diabetic retinopathy, macular edema, ocular rosacea, amblyopia, cataracts, dry eye, iritis, retinitis pigmentosa, uveitis etc.) by administering a creatine compound to a subject.

Creatine Ascorbyl Derivatives And Methods Of Use Thereof

View page
US Patent:
20090098221, Apr 16, 2009
Filed:
May 5, 2008
Appl. No.:
12/151285
Inventors:
Belinda Tsao Nivaggioli - Atherton CA, US
International Classification:
A61K 36/00
C07F 9/09
A61P 25/00
A61P 29/00
A61P 17/00
A61K 31/665
US Classification:
424725, 549222, 514 99
Abstract:
The present invention provides methods of treating creatine responsive states, such as a neurological disorder (i.e., Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, muscular dystrophy, Charcot Marie Tooth syndrome, Alzheimer's disease, or creatine transporter defect) or a skin disorder, by administering a creatine-ascorbyl derivative.

Use Of Creatine Compounds To Treat Dermatitis

View page
US Patent:
20090105196, Apr 23, 2009
Filed:
Jun 23, 2008
Appl. No.:
12/144086
Inventors:
Belinda Tsao NIVAGGIOLI - Atherton CA, US
Maisie Wong-Paredes - Sacramento CA, US
International Classification:
A61K 31/661
A61K 31/195
A61P 17/00
US Classification:
514137, 514565
Abstract:
Creatine compounds for the treatment of dermatitis are described.

Creatine-Ligand Compounds And Methods Of Use Thereof

View page
US Patent:
20110008306, Jan 13, 2011
Filed:
Feb 2, 2010
Appl. No.:
12/698527
Inventors:
Belinda Tsao NIVAGGIOLI - Atherton CA, US
International Classification:
A61K 31/65
C07C 279/14
C07D 307/33
A61K 31/197
A61P 17/00
A61P 25/00
US Classification:
424 941, 562560, 549315, 514565, 514154
Abstract:
The present invention provides methods of treating creatine responsive states, such as a neurological disorder (i.e., Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and creatine transporter defect) or a skin disorder, by administering a creatine-ligand compound, alone or in combination with an anti-inflammatory compound, to a subject.

Creatine Compositions For Skin Treatment

View page
US Patent:
20120065261, Mar 15, 2012
Filed:
Apr 13, 2011
Appl. No.:
13/066291
Inventors:
Belinda Tsao Nivaggioli - Atherton CA, US
Bolko Zu Stolberg - Palo Alto CA, US
Maisie Wong-Paredes - Redwood City CA, US
Assignee:
Avicena Group, Inc. - Redwood City CA
International Classification:
A61K 31/205
A61K 31/197
A61Q 19/00
A61P 17/00
A61P 39/06
A61K 8/43
A61P 29/00
US Classification:
514554, 514565
Abstract:
The present invention relates to the use of creatine compounds, such as, for example, creatine monohydrate, creatine pyruvate and creatine ascorbate, for the treatment of skin.

Methods Of Treating A Neurological Disorder With Creatine Monohydrate

View page
US Patent:
20070292403, Dec 20, 2007
Filed:
May 11, 2007
Appl. No.:
11/803141
Inventors:
Belinda Nivaggioli - Atherton CA, US
Assignee:
AVICENA GROUP, INC. - Boston MA
International Classification:
A61K 31/195
A61K 31/426
A61K 31/65
A61K 38/43
A61P 25/00
A61P 25/16
A61P 25/28
US Classification:
424094100, 514152000, 514367000, 514565000
Abstract:
The present invention provides methods of treating neurological disorders, such as Huntington's disease, Parkinson's disease and amyotrophic lateral sclerosis, by administering creatine monohydrate and dextrose, alone or in combination with an anti-inflammatory compound, to a subject.
Belinda Tsao Nivaggioli from Atherton, CA, age ~57 Get Report